Old Web
English
Sign In
Acemap
>
authorDetail
>
Valérie Berlaimont
Valérie Berlaimont
Virology
Medicine
Letter to the editor
Bivalent (genetics)
human papillomavirus
5
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types
2019
Expert Review of Vaccines
Martin Ryser
Valérie Berlaimont
Naveen Karkada
Attila Mihályi
Rino Rappuoli
Robbert G. van der Most
Show All
Source
Cite
Save
Citations (11)
Letter-to-the-Editor in response to Tanton C, Mesher D, Beddows S, Soldan K, Clifton S, Panwar K, Field N, Mercer CH, Johnson AM, Sonnenberg P. Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41. doi: 10.1016/j.pvr.2017.01.001
2017
Papillomavirus Research
Martin Ryser
Adrienne Guignard
Valérie Berlaimont
Show All
Source
Cite
Save
Citations (0)
Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemporary Clinical Trials 47 (2016) 254–258.
2017
Contemporary Clinical Trials
Nicolas Folschweiller
Valérie Berlaimont
S. Rachel Skinner
Cosette M. Wheeler
Naveen Karkada
Frank Struyf
Martin Ryser
Show All
Source
Cite
Save
Citations (2)
Reply to Poddighe.
2017
The Journal of Infectious Diseases
LouisE. Stevenson
L-M Huang
Valérie Berlaimont
Nicolas Folschweiller
Show All
Source
Cite
Save
Citations (0)
1